Program
14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment
A development code. Also written as “Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.” and “Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®”.
Its studies are mostly in Skin Manifestations · Skin Diseases, led by Botanee Group.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Botanee Group | 31 open or running | no phasesince Oct 31, 2023 | Oct 31, 2023 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 31, 2023First study: no phase study in Cutis LaxaFirst studyNCT06140628 · 37 enrolled · China
- Dec 6, 2023No phase study in Skin ManifestationsNCT06188338 · 24 enrolled · China
- Mar 18, 2025No phase study in Skin DiseasesNCT06891924 · 33 planned
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06891924Skin Diseases | – | Not yet recruiting | Jun 1, 2025 | 33 |
| NCT06188338Skin Manifestations · China | – | Completed | Jan 27, 2024 | 24 |
| NCT06140628Cutis Laxa · China | – | Completed | Nov 7, 2023 | 37 |
How it is read
Names in the registry
- “14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment”, 1 entry
- “Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.”, 1 entry
- “Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®”, 1 entry
Codes read as this program: MLYAAT1002.
Conditions, from the studies’ own filings
- Skin Manifestations, 2 studies
- Skin Diseases, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.